Leerink Partnrs Issues Optimistic Estimate for ARDT Earnings

Ardent Health Partners, LLC (NYSE:ARDT) – Leerink Partnrs lifted their Q4 2025 earnings estimates for Ardent Health Partners in a note issued to investors on Tuesday, April 1st. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings per share of $0.68 for the quarter, up from their prior estimate of $0.61. The consensus estimate for Ardent Health Partners’ current full-year earnings is $1.23 per share. Leerink Partnrs also issued estimates for Ardent Health Partners’ Q1 2026 earnings at $0.38 EPS, Q2 2026 earnings at $0.57 EPS, Q3 2026 earnings at $0.46 EPS and Q4 2026 earnings at $0.66 EPS.

Several other brokerages also recently weighed in on ARDT. Morgan Stanley lowered their target price on shares of Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a report on Tuesday, January 21st. Truist Financial reduced their price target on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a report on Monday, January 6th. Royal Bank of Canada dropped their price objective on Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating on the stock in a report on Tuesday, March 4th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $20.00 target price on shares of Ardent Health Partners in a report on Tuesday, December 17th. Finally, Stephens reaffirmed an “overweight” rating and set a $22.00 price target on shares of Ardent Health Partners in a research note on Tuesday. Two investment analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $21.18.

Ardent Health Partners Price Performance

Shares of NYSE ARDT opened at $12.84 on Thursday. The stock has a fifty day moving average price of $14.34 and a 200 day moving average price of $16.13. Ardent Health Partners has a 1-year low of $10.64 and a 1-year high of $20.72. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78.

Ardent Health Partners (NYSE:ARDT) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.31. The company had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.48 billion.

Hedge Funds Weigh In On Ardent Health Partners

Hedge funds have recently added to or reduced their stakes in the business. Charles Schwab Investment Management Inc. acquired a new stake in shares of Ardent Health Partners in the third quarter valued at approximately $526,000. BNP Paribas Financial Markets purchased a new stake in Ardent Health Partners in the 3rd quarter valued at approximately $42,000. MetLife Investment Management LLC acquired a new stake in Ardent Health Partners during the 3rd quarter valued at $135,000. Centiva Capital LP purchased a new position in Ardent Health Partners during the third quarter worth $469,000. Finally, Point72 Asset Management L.P. acquired a new position in shares of Ardent Health Partners in the third quarter worth $27,428,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.